Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort Analysis - Top-Institutions - MDSpire

Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort Analysis

  • By

  • Rohit Sharma

  • Rajan P. Kulkarni

  • Richard Essner

  • Andrew Ward

  • Andrew H. Lewis

  • Shireen Guide

  • J. Michael Guenther

  • June 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Melanoma

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Melanoma

  • #3

    Melanoma Institute Australia
    Melanoma Institute Australia

    Sydney, New South Wales

    Key Differentiators

    • Oncology
    • Melanoma

Original Source(s)

Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort Analysis

  • by Rohit Sharma, Rajan P. Kulkarni, Richard Essner, Andrew Ward, Andrew H. Lewis, Shireen Guide, J. Michael Guenther

  • June 23, 2026

Related Content

Ultraviolet radiation as a double-edged regulator of melanocyte function in vitiligo therapy and melanoma carcinogenesis

TIL cell therapy in HIV positive patient with metastatic melanoma: case report

Generation of functional canine TIL products for solid tumors